Avalo Therapeutics所有资讯

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Allostery Master Fund LP(7.6%),Allostery Investments LP(7.6%)等

05/14 00:44

Avalo Therapeutics | 10-Q：季度报表

05/13 19:34

Avalo Therapeutics | 8-K：Avalo公布2024年第一季度财务业绩并提供业务最新情况

05/13 19:34

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Emerald Bioventures, LLC(5.6%),Timothy Opler(5.6%)

04/24 03:00

Avalo Therapeutics | D：发行公告

04/10 05:02

Avalo Therapeutics | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%)等

04/06 04:04

Avalo Therapeutics | 3：首次持股声明-董事 Truex Samantha

04/04 04:13

Avalo Therapeutics | 3：首次持股声明-董事 Goldman Jonathan

04/04 04:10

Avalo Therapeutics | 3：首次持股声明-董事 KANTOFF AARON

04/04 04:04

Avalo Therapeutics | 10-K：年度报表

03/30 04:08

Avalo Therapeutics | 8-K：重大事件

03/30 04:08

Avalo Therapeutics | DEFA14A：其他

03/28 18:29

Avalo Therapeutics | 8-K：重大事件

03/28 18:14

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%)等

02/15 10:18

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%)等

02/15 06:35

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%)等

02/15 05:58

Avalo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%)等

02/14 23:08

Avalo Therapeutics | 8-K：重大事件

02/01 05:03

Avalo Therapeutics | 8-K：重大事件

2023/12/28 13:00

Avalo Therapeutics | 4：持股变动声明-董事 Persson Magnus

2023/12/22 05:05